MDxHealth Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Mike McGarrity
Chief executive officer
US$571.1k
Total compensation
| CEO salary percentage | 78.8% |
| CEO tenure | 4.8yrs |
| CEO ownership | n/a |
| Management average tenure | 4.7yrs |
| Board average tenure | 6yrs |
Recent management updates
Recent updates
Why Investors Shouldn't Be Surprised By MDxHealth SA's (EBR:MDXH) 29% Share Price Plunge
Oct 05
MDxHealth (EBR:MDXH) Has Debt But No Earnings; Should You Worry?
Aug 29MDxHealth (EBR:MDXH) Is Carrying A Fair Bit Of Debt
Apr 21Is MDxHealth (EBR:MDXH) Using Debt In A Risky Way?
May 05Here's Why MDxHealth (EBR:MDXH) Can Manage Its Debt Despite Losing Money
Nov 08MDxHealth (EBR:MDXH) Has Debt But No Earnings; Should You Worry?
Mar 23MDxHealth's (EBR:MDXH) Stock Price Has Reduced 75% In The Past Five Years
Jan 29
Is MDxHealth (EBR:MDXH) Weighed On By Its Debt Load?
Nov 27CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -US$45m |
| Jun 30 2023 | n/a | n/a | -US$48m |
| Mar 31 2023 | n/a | n/a | -US$47m |
| Dec 31 2022 | US$571k | US$450k | -US$44m |
| Sep 30 2022 | n/a | n/a | -US$40m |
| Jun 30 2022 | n/a | n/a | -US$34m |
| Mar 31 2022 | n/a | n/a | -US$31m |
| Dec 31 2021 | US$540k | US$386k | -US$29m |
| Sep 30 2021 | n/a | n/a | -US$28m |
| Jun 30 2021 | n/a | n/a | -US$28m |
| Mar 31 2021 | n/a | n/a | -US$28m |
| Dec 31 2020 | US$582k | US$452k | -US$29m |
| Sep 30 2020 | n/a | n/a | -US$36m |
| Jun 30 2020 | n/a | n/a | -US$43m |
| Mar 31 2020 | n/a | n/a | -US$43m |
| Dec 31 2019 | US$442k | US$347k | -US$43m |
Compensation vs Market: Mike's total compensation ($USD571.15K) is about average for companies of similar size in the Belgian market ($USD524.98K).
Compensation vs Earnings: Mike's compensation has increased whilst the company is unprofitable.
CEO
Mike McGarrity (60 yo)
4.8yrs
Tenure
US$571,149
Compensation
Mr. Michael K. McGarrity, also known as Mike, has been the Chief Executive Officer and Executive Director at MDxHealth SA since February 18, 2019. Mr. McGarrity has experience in the healthcare industry wi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 4.8yrs | US$571.15k | no data | |
| Chief Financial Officer | 4.4yrs | no data | 0% € 0 | |
| Executive VP of Corporate Development & General Counsel | no data | no data | 0% € 0 | |
| Chief Commercial Officer | 4.5yrs | no data | 0% € 0 | |
| Executive Vice President of Operations | 4.9yrs | no data | no data | |
| Chief Scientific Officer | no data | no data | no data |
4.7yrs
Average Tenure
52.5yo
Average Age
Experienced Management: MDXH's management team is considered experienced (4.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 4.8yrs | US$571.15k | no data | |
| Independent Non-Executive Director | 2.3yrs | US$76.03k | no data | |
| Independent Non-Executive Director | 6.2yrs | US$49.26k | 0% € 0 | |
| Non-Executive Director | 9.6yrs | US$10.71k | 0% € 0 | |
| Advisor to the Board | 4.8yrs | US$798.45k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 12.8yrs | no data | no data | |
| Member of Scientific Advisory Board | 12.8yrs | no data | no data | |
| Independent Non-Executive Director | 3.3yrs | US$63.18k | 0.22% € 178.2k | |
| Independent Non-Executive Chairman | 5.9yrs | US$109.22k | 0% € 0 | |
| Independent Non-Executive Director | 6.3yrs | US$55.68k | 0% € 0 |
6.0yrs
Average Tenure
59yo
Average Age
Experienced Board: MDXH's board of directors are considered experienced (6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/12/18 10:32 |
| End of Day Share Price | 2023/12/18 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
MDxHealth SA is covered by 13 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Ruzic-Gauthier | Berenberg |
| Mark Massaro | BTIG |
| Roderick Verhelst | Degroof Petercam |